首页|西妥昔单抗对胰腺癌SW1990、PANC-1细胞增殖的影响及其作用机制

西妥昔单抗对胰腺癌SW1990、PANC-1细胞增殖的影响及其作用机制

扫码查看
目的 探讨西妥昔单抗对胰腺癌细胞株SW1990、PANC-1增殖的影响及其作用机制.方法 100.0 μg/mL的西妥昔单抗加入DMEM培养基(西妥昔单抗组),单纯DEME培养基作为空白组,2组分别培养胰腺癌细胞株SW1990、PANC-1,采用MTT法检测SW1990、PANC-1培养12、24、48 h后的生长抑制情况,采用逆转录聚合酶链反应(RT-PCR)、免疫印迹法(Western-blot)检测培养24 h后的2组表皮生长因子受体基因(EGFR-mRNA)及蛋白的表达;采用流式细胞技术检测两组培养24 h后的细胞周期,采用双荧光素酶法检测2组培养24 h后Wnt/β-catenin通路的活性.结果 培养12、24、48 h后,西妥昔单抗组的SW1990、PANC-1细胞株增殖OD值均低于空白组(P<0.05);在24、48 h时,西妥昔单抗组的SW1990、PANC-1细胞株增殖OD值较培养12 h时显著降低(P<0.05);培养24后,西妥昔单抗组的SW1990、PANC-1细胞的G1期细胞比例较空白组显著升高(P<0.05)、S期、G2期细胞比例较空白组显著降低(P<0.05),西妥昔单抗组的SW1990、PANC-1 EGFR-mRNA及蛋白表达均低于空白组(P<0.05),西妥昔单抗组的Wnt/β-catenin通路的活性TOP/FOP值低于空白组(P<0.05).结论 西妥昔单抗对胰腺癌细胞株SW1990、PANC-1细胞增殖具有显著的抑制作用,主要通过降低Wnt/β-catenin通路的活性及EGFR-mRNA及蛋白表达实现.
Effect and mechanism of cetuximab on cell proliferation of SW1990 and PANC-1 cells in pancreatic carcinoma
Objective To investigate the effect of cetuximab on the proliferation of pancreatic carcinoma cell lines SW1990 and PANC-1.Methods 100.0 μg/mL cetuximab added DMEM medium(cetuximab group), simple DEME medium as the control group, two groups of the pancreatic carcinoma cell lines SW1990 and PANC-1 were cultured, the SW1990 and PANC-1 were detected by MTT after cultured 12, 24, 48 h, the expression of epidermal growth factor receptor gene(EGFR-mRNA)and protein in two groups were detected by RT-PCR and Western-blot after 24 h;the cell cycle was detected by flow cytometry after 24 h, the activity of Wnt/ beta-catenin pathway was detected by double luciferase assay after 24 h.Results The OD of the cetuximab group of the SW1990 and PANC-1 cell lines proliferation were lower than the control group after 12, 24, 48 h (P<0.05);the OD of the cetuximab group of the SW1990 and PANC-1 cell lines proliferation in 24, 48 h was significantly decreased than 12 h (P<0.05);the proportion of G1 phase cells of the SW1990 and PANC-1 of the cetuximab group increased significantly than the control group (P<0.05), the proportion of S and G2 phase cells decreased significantly than the control group (P<0.05), the expression of the EGFR-mRNA and protein of the cetuximab group were lower than the control group (P<0.05),the TOP/FOP of the Wnt/beta-catenin pathways' activity of the cetuximab group was lower than that of the control group (P<0.05).Conclusion The proliferation of pancreatic carcinoma cell lines SW1990 and PANC-1 was significantly inhibited by cetuximab, which was mainly achieved by decreasing the activity of Wnt/beta-catenin pathway and the expression of EGFR-mRNA and protein.

cetuximabpancreatic carcinomaSW1990PANC-1proliferationmechanism

吕永强、牛淼

展开 >

中国人民解放军第210医院 检验科,辽宁 大连 116021

西妥昔单抗 胰腺癌 SW1990 PANC-1 增殖 机制

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.(7)
  • 3
  • 11